| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.0018 | 1 |